• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Nature . Influenza vaccination reveals sex dimorphic imprints of prior mild COVID-19

tetano

Editor, Senior Moderator
Nature


. 2023 Jan 4.
doi: 10.1038/s41586-022-05670-5. Online ahead of print.
Influenza vaccination reveals sex dimorphic imprints of prior mild COVID-19


Rachel Sparks[SUP] #[/SUP][SUP] 1 [/SUP], William W Lau[SUP] #[/SUP][SUP] 1 [/SUP], Can Liu[SUP] #[/SUP][SUP] 1 2 [/SUP], Kyu Lee Han[SUP] 3 [/SUP], Kiera L Vrindten[SUP] 1 [/SUP], Guangping Sun[SUP] 1 4 [/SUP], Milann Cox[SUP] 1 [/SUP], Sarah F Andrews[SUP] 5 [/SUP], Neha Bansal[SUP] 1 [/SUP], Laura E Failla[SUP] 1 [/SUP], Jody Manischewitz[SUP] 6 [/SUP], Gabrielle Grubbs[SUP] 6 [/SUP], Lisa R King[SUP] 6 [/SUP], Galina Koroleva[SUP] 3 [/SUP], Stephanie Leimenstoll[SUP] 7 [/SUP], LaQuita Snow[SUP] 7 [/SUP]; OP11 Clinical Staff; Jinguo Chen[SUP] 3 [/SUP], Juanjie Tang[SUP] 6 [/SUP], Amrita Mukherjee[SUP] 3 [/SUP], Brian A Sellers[SUP] 3 [/SUP], Richard Apps[SUP] 3 [/SUP], Adrian B McDermott[SUP] 5 [/SUP], Andrew J Martins[SUP] 1 [/SUP], Evan M Bloch[SUP] 8 [/SUP], Hana Golding[SUP] 6 [/SUP], Surender Khurana[SUP] 6 [/SUP], John S Tsang[SUP] 9 10 [/SUP]



Collaborators, Affiliations

Abstract

Acute viral infections can have durable functional impacts on the immune system long after recovery, but how they affect homeostatic immune states and responses to future perturbations remain poorly understood[SUP]1-4[/SUP]. Here we use systems immunology approaches, including longitudinal multimodal single cell analysis (surface proteins, transcriptome, and V(D)J sequences), to comparatively assess baseline immune statuses and responses to influenza vaccination in 33 healthy individuals after recovery from mild, non-hospitalized COVID-19 (mean: 151 days after diagnosis) and 40 age- and sex-matched controls who never had COVID-19. At baseline and independent of time since COVID-19, recoverees had elevated T-cell activation signatures and lower expression of innate immune genes in monocytes. COVID-19-recovered males had coordinately higher innate, influenza-specific plasmablast, and antibody responses after vaccination compared to healthy male and COVID-19-recovered females, partly because male recoverees had monocytes with higher IL-15 responses early after vaccination coupled with elevated pre-vaccination frequencies of "virtual memory" like CD8+ T-cells poised to produce more IFNγ upon IL-15 stimulation. In addition, the expression of the repressed innate immune genes in monocytes increased by day 1 through day 28 post-vaccination in recoverees, thus moving towards the pre-vaccination baseline of healthy controls. In contrast, these genes decreased on day 1 and returned to the baseline by day 28 in controls. Our study reveals sex-dimorphic impacts of prior mild COVID-19 and suggests that viral infections in humans can establish new set-points impacting future immune responses in an antigen-agnostic manner.
 
Back
Top Bottom